LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 34.30 | 27.76 | 1350 | 2449 | 0.5511 | 0.8239 | MN20160318_Q01 | N05 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 36.01 | 27.76 | 429 | 2662 | 0.1611 | 0.5157 | MN20160318_Q01 | D18 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 36.01 | 27.76 | 915 | 2662 | 0.3436 | 0.7005 | MN20160318_Q01 | D18 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 36.01 | 27.76 | 38 | 2662 | 0.0143 | 0.0489 | MN20160318_Q01 | F14 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 36.01 | 27.76 | 1001 | 2662 | 0.3759 | 0.7238 | MN20160318_Q01 | F14 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 36.01 | 27.76 | 1262 | 2662 | 0.4739 | 0.7856 | MN20160318_Q01 | N05 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 36.01 | 27.76 | 1271 | 2662 | 0.4773 | 0.7875 | MN20160318_Q01 | N05 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 37.71 | 27.76 | 531 | 2877 | 0.1845 | 0.5539 | MN20160318_Q01 | D18 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 37.71 | 27.76 | 1130 | 2877 | 0.3927 | 0.7394 | MN20160318_Q01 | D18 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 37.71 | 27.76 | 38 | 2877 | 0.0132 | 0.0480 | MN20160318_Q01 | F14 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 37.71 | 27.76 | 1015 | 2877 | 0.3527 | 0.7118 | MN20160318_Q01 | F14 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 37.71 | 27.76 | 1401 | 2877 | 0.4869 | 0.7962 | MN20160318_Q01 | N05 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 37.71 | 27.76 | 1414 | 2877 | 0.4914 | 0.7986 | MN20160318_Q01 | N05 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 39.41 | 27.76 | 668 | 3105 | 0.2151 | 0.5958 | MN20160318_Q01 | D18 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 39.41 | 27.76 | 1110 | 3105 | 0.3574 | 0.7194 | MN20160318_Q01 | D18 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 39.41 | 27.76 | 53 | 3105 | 0.0171 | 0.0997 | MN20160318_Q01 | F14 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 39.41 | 27.76 | 1148 | 3105 | 0.3697 | 0.7279 | MN20160318_Q01 | F14 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 39.41 | 27.76 | 1528 | 3105 | 0.4920 | 0.8021 | MN20160318_Q01 | N05 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 39.41 | 27.76 | 1544 | 3105 | 0.4972 | 0.8048 | MN20160318_Q01 | N05 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 41.11 | 27.76 | 867 | 3331 | 0.2602 | 0.6459 | MN20160318_Q01 | D18 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 41.11 | 27.76 | 1181 | 3331 | 0.3545 | 0.7212 | MN20160318_Q01 | D18 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 41.11 | 27.76 | 65 | 3331 | 0.0195 | 0.1311 | MN20160318_Q01 | F14 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 41.11 | 27.76 | 1181 | 3331 | 0.3545 | 0.7212 | MN20160318_Q01 | F14 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 41.11 | 27.76 | 1554 | 3331 | 0.4665 | 0.7909 | MN20160318_Q01 | N05 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 41.11 | 27.76 | 1569 | 3331 | 0.4710 | 0.7934 | MN20160318_Q01 | N05 |